COSCIENS Biopharma OverviewCOSCIENS Biopharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CSCI.
Quarterly EBIT
-$2.68M
↓ 42.87% YoY
As of Jun 30, 2025
Annual EBIT (TTM)
-$17.72M
↓ 167.04% YoY
Trailing 12 months ending Jun 30, 2025
COSCIENS Biopharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for CSCI.
As of Jun 30, 2025
Trailing 12 months ending Jun 30, 2025